Palvella Therapeutics, Inc. financial data

Symbol
PVLA on Nasdaq
Location
125 Strafford Ave, Suite 360, Wayne, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 753 %
Debt-to-equity 50.7 %
Return On Assets -42.7 % -135%
Operating Margin 270 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.8M shares +797%
Common Stock, Shares, Outstanding 11.1M shares +740%
Entity Public Float 9.2M USD -18%
Common Stock, Value, Issued 11K USD +1000%
Weighted Average Number of Shares Outstanding, Basic 11.1M shares +525%
Weighted Average Number of Shares Outstanding, Diluted 11.1M shares +525%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.35M USD -97.1%
Research and Development Expense 18.3M USD +105%
General and Administrative Expense 13.4M USD +94.1%
Operating Income (Loss) -31.7M USD -966%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33M USD -67.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -32.9M USD -231%
Earnings Per Share, Basic -2 USD/shares -119%
Earnings Per Share, Diluted -2 USD/shares +73.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.6M USD +228%
Cash, Cash Equivalents, and Short-term Investments 19.4M USD -56.7%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 66.9M USD
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 66.9M USD +226%
Accounts Payable, Current 3.48M USD +335%
Employee-related Liabilities, Current 1.25M USD -45.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 10.3M USD +142%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD
Liabilities 28.3M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 104K USD
Retained Earnings (Accumulated Deficit) -123M USD +62.4%
Stockholders' Equity Attributable to Parent 38.7M USD
Liabilities and Equity 66.9M USD +226%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.77M USD -514%
Net Cash Provided by (Used in) Financing Activities -1.2M USD
Net Cash Provided by (Used in) Investing Activities 9M USD -24.4%
Common Stock, Shares Authorized 200M shares +5233%
Common Stock, Shares, Issued 11.1M shares +740%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.98M USD -624%
Deferred Tax Assets, Valuation Allowance 93.3M USD +482%
Deferred Tax Assets, Gross 93.3M USD +482%
Operating Lease, Liability 12.3M USD +0.62%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.3M USD -235%
Lessee, Operating Lease, Liability, to be Paid 18.4M USD -3.37%
Property, Plant and Equipment, Gross 26.7M USD +3.93%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.09M USD +7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.09M USD +7.91%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.14M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.09M USD +7.91%
Deferred Tax Assets, Operating Loss Carryforwards 82M USD +793%
Preferred Stock, Shares Issued 15.6K shares -0.01%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD +7.91%
Operating Lease, Payments 700K USD -68.2%
Additional Paid in Capital 161M USD -53%
Preferred Stock, Shares Outstanding 15.6K shares -0.01%
Depreciation, Depletion and Amortization 605K USD -28.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 4.59M USD +799%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%